Prof. Dr. med. Albrecht Stenzinger

Deputy Director, Institute of Pathology, Heidelberg (IPH), Germany

Professor of Molecular Tumor Pathology, Ruprecht-Karls-University Heidelberg, Germany          

Head, Center for Molecular Pathology (CMP) of the Institute of Pathology (IPH), and Section Head Molecular Pathology and Biomarker Development, University Hospital Heidelberg, Germany

Senior Consultant Pathologist, Institute of Pathology (IPH), University Hospital Heidelberg, Germany

Board Exam in Pathology

Residency in Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany

Residency in Pathology, Institute of Pathology, Charité University Hospital, Berlin, Germany

Senior Research Fellow, Massachusetts General Hospital, Harvard Medical School, Boston, USA

Fellow of the Heidelberg School of Oncology (HSO) at the National Center for Tumor Diseases (NCT), Heidelberg, Germany

PostDoc, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany

Justus-Liebig University Giessen Faculty of Medicine, Germany Doctoral thesis (Dr.med.): summa cum laude

Justus-Liebig University Giessen Medical School, Germany M.D. degree

Internship: Dept. of Visceral-, Transplant- and Thoracic Surgery and Dept. of Trauma Surgery, Justus Liebig University Giessen Medical School, Germany Institute of Pathology, St. Gallen, Switzerland Dept. of Internal Medicine, University Hopital Basel, Switzerland

MD Anderson Cancer Center (MDACC), Houston, Texas, USA

University Medical Center Groningen, NL

Queen’s University Belfast Medical School, UK

Justus-Liebig University Giessen Medical School, Germany

Proffered Paper, selected abstract ESMO-IO

Visiting Professor, University of Belgrade, Serbia

ISLAC Asia 2018, Best Abstract Award

Heidelberg School of Oncology (HSO) Fellowship

EACR Meeting Award “3rd EACR-EOCI Joint Training Course: Molecular Pathology Approach to Cancer”

Award, Pathologist-in-Training Academy of the German Society of Pathology (DGP), Germany

Postdoc-Grant (Young Investigator Award) of the Medical Faculty of the University Heidelberg

American Association for Cancer Research (AACR)

Association for Molecular Pathology (AMP)

Arbeitsgemeinschaft Internistische Onkologie (AIO)

American Society of Clincial Oncology (ASCO)

Deutsche Gesellschaft für Pathologie (DGP)

Deutsche Krebsgesellschaft (DKH)

The European Association for Cancer Research (EACR)

European Society for Medical Oncology (ESMO)

Principal Investigator, German Center for Lung Research (DZL)

Speaker, Working Group Diagnostics, Zentren für Personalisierte Medizin (ZPM), Baden-Wurttemberg, Germany

Member, Scientific Advisory Board, Genomic Medicine Sweden (GMS)

Member, Working Groups Genomics and Pathology, Cancer Core Europe

Co-Investigator and Member Scientific Board, MASTER-Program, NCT Heidelberg, Germany
                                   

Tumor genetics
Immuno-Oncology
Drug targets
Predictive biomarkers
Complex biomarkers
Lung cancer

Rubrikherausgeber ‘Molekulares Tumorboard’, der Pathologe

Associate Editor, Genes Chromosomes Cancer

Editoral Board, Translational Lung Cancer Research

https://scholar.google.de/citations?user=lKKqENkAAAAJ&hl=de

https://pubmed.ncbi.nlm.nih.gov/?term=stenzinger+a